A trickling launch for Aduhelm and a middling earnings report give Biogen executives a lot to talk about. Is there hope?
A trickling launch for Aduhelm and a middling earnings report give Biogen executives a lot to talk about. Is there hope?
Copyright © 2024 | WordPress Theme by MH Themes